Clinical trial
Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy
NCT04096014 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy
- Lead sponsor
- The Cleveland Clinic
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 16, 2019
- Completion date
- October 30, 2028
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.